Form 6-K InflaRx N.V. For: Mar 31
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
FORM 6-K
|
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2026
Commission File Number: 001-38283
|
InflaRx N.V.
(Translation of registrant's name into English)
|
|
Winzerlaer Str. 2
07745 Jena, Germany
(Address of principal executive office)
|
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Exhibits 99.1 and 99.2 to this report on Form 6-K (this “Report”) shall be deemed to be incorporated by reference into (i) the registration statements on Form S-8 (File No. 333-221656 and 333-240185) and (ii)
the registration statement on Form F-3 (File No. 333-273058) of InflaRx N.V. and to be a part thereof
from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
|
Exhibit No.
|
Description
|
|
InflaRx N.V. Unaudited Condensed Consolidated Financial Statements as of and for the Three Months Ended March 31, 2026
|
|
|
InflaRx N.V. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
INFLARX N.V.
|
|||
|
Date: May 6, 2026
|
By:
|
/s/ Niels Riedemann
|
|
|
Name:
|
Niels Riedemann
|
||
|
Title:
|
Chief Executive Officer
|
||
ATTACHMENTS / EXHIBITS